513 related articles for article (PubMed ID: 27241369)
1. In vitro activity of dalbavancin against biofilms of staphylococci isolated from prosthetic joint infections.
Fernández J; Greenwood-Quaintance KE; Patel R
Diagn Microbiol Infect Dis; 2016 Aug; 85(4):449-51. PubMed ID: 27241369
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of ceftaroline against staphylococci from prosthetic joint infection.
Park KH; Greenwood-Quaintance KE; Patel R
Diagn Microbiol Infect Dis; 2016 Feb; 84(2):141-3. PubMed ID: 26602948
[TBL] [Abstract][Full Text] [Related]
3. In vitro susceptibility to antibiotics of staphylococci in biofilms isolated from orthopaedic infections.
Molina-Manso D; del Prado G; Ortiz-Pérez A; Manrubia-Cobo M; Gómez-Barrena E; Cordero-Ampuero J; Esteban J
Int J Antimicrob Agents; 2013 Jun; 41(6):521-3. PubMed ID: 23611308
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of oritavancin against biofilms of staphylococci isolated from prosthetic joint infection.
Yan Q; Karau MJ; Patel R
Diagn Microbiol Infect Dis; 2018 Oct; 92(2):155-157. PubMed ID: 29885758
[TBL] [Abstract][Full Text] [Related]
5. Dalbavancin reduces biofilms of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant Staphylococcus epidermidis (MRSE).
Knafl D; Tobudic S; Cheng SC; Bellamy DR; Thalhammer F
Eur J Clin Microbiol Infect Dis; 2017 Apr; 36(4):677-680. PubMed ID: 27896496
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of TNP-2092 against periprosthetic joint infection-associated staphylococci.
Fisher CR; Schmidt-Malan SM; Ma Z; Yuan Y; He S; Patel R
Diagn Microbiol Infect Dis; 2020 Jul; 97(3):115040. PubMed ID: 32354459
[TBL] [Abstract][Full Text] [Related]
7. In vitro antibiotic efficacy against staphylococci embedded in a biofilm involved in prosthetic joint infections: A MBEC problem?
Corvec S; Aubin GG
Int J Antimicrob Agents; 2015 Jan; 45(1):90. PubMed ID: 25465522
[No Abstract] [Full Text] [Related]
8. In vitro activity of dalbavancin and telavancin against staphylococci and streptococci isolated from patients in Canadian hospitals: results of the CANWARD 2007-2009 study.
Karlowsky JA; Adam HJ; Poutanen SM; Hoban DJ; Zhanel GG;
Diagn Microbiol Infect Dis; 2011 Mar; 69(3):342-7. PubMed ID: 21353963
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of dalbavancin against staphylococci isolated in Istanbul, Turkey.
Aktas G; Derbentli S
Chemotherapy; 2010; 56(6):444-7. PubMed ID: 21088395
[TBL] [Abstract][Full Text] [Related]
10. In vitro susceptibility of Staphylococcus aureus and Staphylococcus epidermidis isolated from prosthetic joint infections.
Molina-Manso D; del Prado G; Ortiz-Pérez A; Manrubia-Cobo M; Gómez-Barrena E; Cordero-Ampuero J; Esteban J
J Antibiot (Tokyo); 2012 Oct; 65(10):505-8. PubMed ID: 22854340
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic and genotypic characterization of Staphylococci causing breast peri-implant infections in oncologic patients.
Barbieri R; Pesce M; Franchelli S; Baldelli I; De Maria A; Marchese A
BMC Microbiol; 2015 Feb; 15(1):26. PubMed ID: 25888077
[TBL] [Abstract][Full Text] [Related]
12. Can dalbavancin be used as a catheter lock solution?
Díaz-Ruíz C; Alonso B; Cercenado E; Cruces R; Bouza E; Muñoz P; Guembe M
J Med Microbiol; 2018 Jul; 67(7):936-944. PubMed ID: 29771236
[No Abstract] [Full Text] [Related]
13. In vitro activity of tedizolid against staphylococci isolated from prosthetic joint infections.
Schmidt-Malan SM; Greenwood Quaintance KE; Karau MJ; Patel R
Diagn Microbiol Infect Dis; 2016 May; 85(1):77-9. PubMed ID: 26906190
[TBL] [Abstract][Full Text] [Related]
14. Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections.
Saginur R; Stdenis M; Ferris W; Aaron SD; Chan F; Lee C; Ramotar K
Antimicrob Agents Chemother; 2006 Jan; 50(1):55-61. PubMed ID: 16377667
[TBL] [Abstract][Full Text] [Related]
15. Inefficacy of vancomycin and teicoplanin in eradicating and killing Staphylococcus epidermidis biofilms in vitro.
Claessens J; Roriz M; Merckx R; Baatsen P; Van Mellaert L; Van Eldere J
Int J Antimicrob Agents; 2015 Apr; 45(4):368-75. PubMed ID: 25614358
[TBL] [Abstract][Full Text] [Related]
16. Antibacterial and anti-biofilm activities of thiazolidione derivatives against clinical staphylococcus strains.
Liu H; Zhao Y; Zhao D; Gong T; Wu Y; Han H; Xu T; Peschel A; Han S; Qu D
Emerg Microbes Infect; 2015 Jan; 4(1):e1. PubMed ID: 26038759
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of oritavancin in combination with rifampin or gentamicin against prosthetic joint infection-associated methicillin-resistant Staphylococcus epidermidis biofilms.
Yan Q; Karau MJ; Raval YS; Patel R
Int J Antimicrob Agents; 2018 Nov; 52(5):608-615. PubMed ID: 30048689
[TBL] [Abstract][Full Text] [Related]
18. Planktonic and Biofilm Activity of Eravacycline against Staphylococci Isolated from Periprosthetic Joint Infections.
Zhuchenko G; Schmidt-Malan S; Patel R
Antimicrob Agents Chemother; 2020 Nov; 64(12):. PubMed ID: 32988818
[TBL] [Abstract][Full Text] [Related]
19. Effect of different agents with potential antibiofilm activity on antimicrobial susceptibility of biofilms formed by Staphylococcus spp. isolated from implant-related infections.
Molina-Manso D; Del-Prado G; Gómez-Barrena E; Cordero-Ampuero J; Fernandez-Roblas R; Esteban J
J Antibiot (Tokyo); 2016 Sep; 69(9):686-8. PubMed ID: 26905757
[TBL] [Abstract][Full Text] [Related]
20. Dalbavancin treatment of prosthetic knee infection due to oxacillin-resistant Staphylococcus epidermidis.
Ramírez Hidalgo M; Jover-Sáenz A; García-González M; Barcenilla-Gaite F
Enferm Infecc Microbiol Clin (Engl Ed); 2018 Feb; 36(2):142-143. PubMed ID: 28600171
[No Abstract] [Full Text] [Related]
[Next] [New Search]
